C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

C4 Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$621000.0 for Q3 2023.

• In Q3 2023, Other Non Operating Income changed N/A year-over-year to -$621000.0; the TTM figure through Dec 2024 stood at -$621000.0 (changed 0.0% YoY), while the FY2023 annual figure was -$621000.0, changed N/A from the prior year.
• Other Non Operating Income for Q3 2023 stood at -$621000.0, down from $43000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $43000.0 in Q3 2020, with the low at -$621000.0 in Q3 2023.
• The 3-year median for Other Non Operating Income is -$1000.0 (2019), against an average of -$193000.0.
• Peak annual rise in Other Non Operating Income reached 4400.0% in 2020, while the deepest fall reached 4400.0% in 2020.
• C4 Therapeutics' Other Non Operating Income stood at -$1000.0 in 2019, then jumped by 4400.0% to $43000.0 in 2020, then slumped by 1544.19% to -$621000.0 in 2023.
• Business Quant data shows CCCC's Other Non Operating Income at -$621000.0 in Q3 2023, $43000.0 in Q3 2020, and -$1000.0 in Q3 2019.